Samina Badar

St George & Sutherland Clinical School
Sydney, NSW 2217, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Preclinical assessment of inhalational subacute safety of nebulized MP-171 (BromAc®).

Preclinical assessment of inhalational subacute safety of nebulized MP-171 (BromAc®).

Journal: BMC pulmonary medicine

Published: October 20, 2025

Erratum: Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies.

Erratum: Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies.

Journal: American journal of cancer research

Published: January 29, 2025

Safety of BromAc® with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study.

Safety of BromAc® with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study.

Journal: American journal of cancer research

Published: November 24, 2024

Retraction: Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer.

Retraction: Minocycline Targets the NF-κB Nexus through Suppression of TGF-β1-TAK1-IκB Signaling in Ovarian Cancer.

Journal: Molecular cancer research : MCR

Published: April 02, 2024

Intraperitoneal BromAc® Does Not Interfere with the Healing of Colon Anastomosis.

Intraperitoneal BromAc® Does Not Interfere with the Healing of Colon Anastomosis.

Journal: Cancers

Published: May 09, 2023

Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection.

Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection.

Journal: American journal of translational research

Published: September 01, 2021

A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.

A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.

Journal: American journal of translational research

Published: July 18, 2021

Physical and chemical factors affecting the loading and release of bromelain from DC beads.

Physical and chemical factors affecting the loading and release of bromelain from DC beads.

Journal: American journal of translational research

Published: June 29, 2021

The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study.

The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study.

Journal: Discover oncology

Published: May 09, 2021

Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways.

Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways.

Journal: American journal of cancer research

Published: March 01, 2021

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.

Journal: Viruses

Published: January 31, 2021

Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition in vivo in human colon cancer cell line LS174T.

Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition in vivo in human colon cancer cell line LS174T.

Journal: American journal of cancer research

Published: November 23, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026